Immune responses in rats and sheep induced by a DNA vaccine containing the phosphoglycerate kinase gene of Fasciola hepatica and liver fluke infection

Agnieszka Wesołowska; Anna Zawistowska-Deniziak; Luke J. Norbury; Przemysław Wilkowski; Kamil Januszkiewicz; Anna M. Pyziel; Wojciech Zygner; Halina Wędrychowicz

doi:10.1515/ap-2016-0030

Article

Immune responses in rats and sheep induced by a DNA vaccine containing the phosphoglycerate kinase gene of Fasciola hepatica and liver fluke infection

Agnieszka Wesołowska , Anna Zawistowska-Deniziak , Luke J. Norbury , Przemysław Wilkowski , Kamil Januszkiewicz , Anna M. Pyziel , Wojciech Zygner and Halina Wędrychowicz

Published/Copyright: March 30, 2016

Published by

Become an author with De Gruyter Brill

Author Information

From the journal Acta Parasitologica Volume 61 Issue 2

Abstract

Immune responses of rats and sheep following vaccination with cDNA encoding phosphoglycerate kinase of Fasciola hepatica (cDNA-FhPGK/pCMV) and F. hepatica infection were investigated in the present study. cDNA-FhPGK/pCMV vaccinated female Sprague-Dawley rats were better protected by vaccination than their male counterparts – 48% reduction in fluke burden for females and no protection for males when compared with appropriate infection control groups. Moreover, male rats developed marked leukocytosis during the study with higher neutrophil, eosinophil and monocyte responses than females. Additionally, dynamics of eosinophil and monocyte responses varied between sexes. Increased titres of anti-FhPGK IgG1 and IgG2a correlated with the protective effect of vaccination that was observed among female rats. In the case of male sheep, no differences in worm burdens and in the course of the immune response were observed following vaccination. Titres of specific antibodies detected were low, and cellular responses were not significant. Apparently, sheep immune responses induced by cDNA-FhPGK/pCMV vaccination are not effective at controlling F. hepatica infection. Poor immunogenicity of DNA vaccines in large animals is still a major obstacle of this technology that has to be overcome.

Keywords: Fasciola hepatica; immune response; DNA vaccine; phosphoglycerate kinase

Acknowledgements

This work was supported by a grant from the National Science Centre no. 2011/01/N/NZ6/00892 and by a grant from the European Union – the DELIVER project, no. FOOD-CT200X-023025.

References

Anthony R.M., Rutitzky L.I., Urban J.F., Stadecker M.J., Gause W.C. 2007. Protective immune mechanisms in helminth infection. Nature Reviews Immunology, 7, 957–987. DOI: 10.1038/ nri21990.1016/S0264-410X(00)00095-5Search in Google Scholar

Brockwell Y.M., Elliott T.P., Anderson G.R., Stanton R., Spithill T.W., Sangster N.C. 2014. Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle. International Journal for Parasitology: Drugs and Drug Resistance, 4, 48–54. DOI: 10.1016/j.ijpddr.2013.11.00510.1038/ nri2199Search in Google Scholar

Cervi L., Serradell M.C., Guasconi L., Masih D.T. 2009. New insights into the modulation of immune response by Fasciola hepatica excretory-secretory products. Current Immunology Reviews, 5, 227–284. DOI: 10.2174/15733950978950396110.1016/j.ijpddr.2013.11.005Search in Google Scholar

Chauvin A., Bouvet G., Boulard C. 1995. Humoral and cellular immune responses to Fasciola hepatica experimental primary and secondary infection in sheep. International Journal for Parasitology, 25, 1227–1241. DOI: 10.1016/0020-7519(95)00039-510.2174/157339509789503961Search in Google Scholar

Cruz-Revilla C., Rosas G., Fragoso G., López-Casillas F., Toledo A., Larralde C., Sciutto E. 2000. Taenia crassiceps cysticercosis: protective effect and immune response elicited by DNA immunization. Journal of Parasitology, 86, 67–74. DOI: http://dx.doi.org/10.1645/0022-3395(2000)086[0067:TCCPEA]2.0.CO;210.1016/0020-7519(95)00039-5Search in Google Scholar

Gajewska A., Smaga-Kozłowska K., Wiśniewski M. 2005. Zmiany patologiczne wątroby w inwazji przywry Fasciola hepatica. Wiadomości Parazytologiczne, 51, 115–123.http://dx.doi.org/10.1645/0022-3395(2000)086[0067:TCC-PEA]2.0.CO;2Search in Google Scholar

Gordon D.K., Zadoks R.N., Stevenson H., Sargison N.D., Skuce P.J. 2012. On farm evaluation of the coproantigen ELISA and coproantigen reduction test in Scottish sheep naturally infected with Fasciola hepatica. Veterinary Parasitology, 187, 436–444. DOI: 10.1016/j.vetpar.2012.02.00910.1016/j.vetpar.2012.02.009Search in Google Scholar

Haroun E.M., Hillyer G.V. 1986. Resistance to fasciolosis – a review. Veterinary Parasitology, 20, 63–93. DOI: 10.1016/ 0304-4017(86)90093-210.1016/j.vetpar.2012.02.009Search in Google Scholar

Hillyer G.V. 2005. Fasciola antigens as vaccines against fascioliasis and schisosomiasis. Journal of Helminthology, 79, 241–247. DOI: 10.1079/JOH200530410.1016/ 0304-4017(86)90093-2Search in Google Scholar

Jacobsen E.A., Taranova A.G., Lee N.A., Lee J.J. 2007. Eosinophils: singularly destructive effect or cells or purveyors of immuneregulation? Journal of Allergy and Clinical Immunology, 119, 1313–1320. DOI: 10.1016/j.jaci.2007.03.04310.1079/JOH2005304Search in Google Scholar

Jaros S., Jaros D., Wesolowska A., Zygner W., Wędrychowicz H. 2010. Blocking Fasciola hepatica’s energy metabolism – a pilot study of vaccine potential of a novel gene – phosphoglycerate kinase. Veterinary Parasitology, 172, 229–237. DOI: 10.1016/j.vetpar.2010.05.00810.1016/j.jaci.2007.03.043Search in Google Scholar

Jaros S., Wesołowska A., Jaros D., Zygner W., Wędrychowicz H. 2011. Molecular cloning and characterization of phosphoglycerate kinase from Fasciola hepatica. Bulletin of the Veterinary Institute in Pulawy, 55, 417–422.10.1016/j.vetpar.2010.05.008Search in Google Scholar

Jenkis M., Kerr D., Fayer R., Wall R. 1995. Serum and colostrum antibody responses induced by jet-injection of sheep with DANN encoding a Cryptosporidium parvum antigen. Vaccine, 13, 1658–16664. DOI: 10.1016/0264-410X(95)00121-G10.1016/0264-410X(95)00121-GSearch in Google Scholar

Klein S. 2012. Sex differences in prophylaxis and therapeutic treatments for viral diseases. Handbook of Experimental Pharmacology, 214, 499–522. DOI: 10.1007/978-3-642-30726-3_2210.1016/0264-410X(95)00121-GSearch in Google Scholar

Klein S.L. 2004. Hormonal and immunological mechanisms mediating sex differences in parasite infection. Parasite Immunology, 26, 247–264. DOI: 10.1111/j.0141-9838.2004.00710.x10.1007/978-3-642-30726-3_22Search in Google Scholar

Klein S.L., Jedlicka A., Pekosz A. 2010. The Xs and Y of immune responses to viral vaccines. The Lancet Infecious. Diseases,10, 338–49. DOI: 10.1016/S1473-3099(10)70049-910.1111/j.0141-9838.2004.00710.xSearch in Google Scholar

Kofta W, Mieszczanek J, Płucienniczak G, Wędrychowicz H. 2000. Successful immunization of rats against fasciolosis. Vaccine, 18, 2985–2990. DOI: 0.1016/S0264-410X(00)00095-510.1016/S1473-3099(10)70049-9Search in Google Scholar

Maggioli G., Acosta D., Silveira F., Rossi S., Giacaman S., Basika T., Gayo V., Rosalida D., Roche L., Tort J., Carmona C. 2011. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep. Vaccine, 29, 9057–63. DOI: 10.1016/j.vaccine.2011.09.02010.1016/j.vaccine.2011.09.020Search in Google Scholar

Mulcahy G., O`Connor F., McGonigle S., Dowd A., Clery D.G., Andrews S.J., Dalton J.P. 1998. Correlation of specific antibody titre and avidity with protection in cattle immunizes against Fasciola hepatica. Vaccine, 16: 932–939. DOI: 10.1016/j.vaccine.2011.09.02010.1016/j.vaccine.2011.09.020Search in Google Scholar

Paz A., Sánchez-Andrade R., Panadero R., Díez-Baňos P., Morrondo P. 1998. IgG isotype specific immune response in rats infected with Fasciola hepatica. Veterinary Parasitology, 79, 229–237. DOI: 10.1016/S0304-4017(98)00165-410.1016/S0304-4017(98)00165-4Search in Google Scholar

Piacenza L., Acosta D., Basmadijan I., Dalton J.P., Carmona C 1999. Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep. Infection and Immunity, 67, 1954–1961. DOI: 0019-9567/99/$04.00100019-9567/99/&dollar;04.0010Search in Google Scholar

Piedrafita D., Parsons J.C., Sandeman M.R., Wood P.R., Estuningsih S.E., Partoutomo S., Spithill T.W. 2001. Antibody-dependent cell-mediated cytotoxicity to newly excysted juvenile Fasciola hepatica in vitro is mediated by reactive nitrogen intermediates. Parasite Immunology, 23, 473–482. DOI: 10.1046/ j.1365-3024.2001.00404.x10.1046/ j.1365-3024.2001.00404.xSearch in Google Scholar

Piedrafita D., Raadsma H.W., Prowse R., Spithill T.W. 2004. Immunology of the host-parasite relationship in fasciolosis (Fasciola hepatica and Fasciola gigantica). Canadian Journal of Zoology, 82, 233–250. DOI: 10.1139/z03-21610.1139/z03-216Search in Google Scholar

Raadsma H.W., Kingsford N.M., Suharyanta, Spithill T.W., Piedrafita D. 2007. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection. Veterinary Parasitology, 143, 275–286. DOI: 10.1016/j.vetpar.2006.09.00810.1016/j.vetpar.2006.09.008Search in Google Scholar

Rothel J.S., Waterkeyn J.G., Strugnell R.A., Wood P.R., Seow H.F., Vadolas J., Lightowlers M.W. 1997. Nucleic acid vaccination of sheep: use in combination with a conventional adjuvanted vaccine against Taenia ovis. Immunology and Cell Biology, 75, 41–46. DOI: 10.1038/icb.1997.710.1038/icb.1997.7Search in Google Scholar

Shi F., Zhang Y., Ye P., Lin J., Cai Y., Shen W., Bickle Q.D., Taylor M.G. 2002. Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China. Vaccine, 20, 3629–3631. DOI: 10.1016/S0264-410X(01)00 340-110.1016/S0264-410X(01)00 340-1Search in Google Scholar

Smooker P.M., Rainczuk A., Kennedy N., Spithill T.W. 2004. DNA vaccines and their application against parasites – promise, limitations and potential solutions. Biotechnology Annual Review, 10, 189–236. DOI: 10.1016/S1387-2656(04)10007-010.1016/S1387-2656(04)10007-0Search in Google Scholar

Toet H., Piedrafita D.M., Spithill T.W. 2014. Liver fluke vaccines in ruminants: strategies, progress and future opportunities. International Journal of Parasitology, 44, 915–927. DOI: 10.1016/j.ijpara.2014.07.01110.1016/j.ijpara.2014.07.011Search in Google Scholar

van Milligen F.J., Cornelissen J.B., Bokhout B.A. 1999. Protection against Fasciola hepatica in the intestine is highly correlated with eosinophil and immunoglobulin G1 response against newly excysted juveniles. Parasite Immunology, 21, 243–251. DOI: 10.1046/j.1365-3024.1999.00226.x10.1046/j.1365-3024.1999.00226.xSearch in Google Scholar

Vollmer J. 2006. CpG motifs to modulate innate and adaptive immune responses. International Reviews of Immunology, 25, 125–134. DOI: 10.1080/0883018060074311510.1080/08830180600743115Search in Google Scholar

Wesołowska A, Norbury L.J., Januszkiewicz K., Jedlina L., Jaros S., Zawistowska-Deniziak A., Zygner W., Wędrychowicz H. 2013. Evaluation of the immune response of male and female rats vaccinated with cDNA encoding a cysteine proteinase of Fasciola hepatica (FhPcW1). Acta Parasitologica, 58, 198–206. DOI: 10.2478/s11686-013-0120-310.2478/s11686-013-0120-3Search in Google Scholar PubMed

Zhang W.Y., Moreau E., Hope J.C., Howard C.J., Huang W.Y., Chauvin A. 2005. Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep. Experimental Parasitology, 111, 154–159. DOI: 10.1016/j.exppara.2005.06.00510.1016/j.exppara.2005.06.005Search in Google Scholar PubMed

Received: 2015-6-22

Revised: 2015-10-12

Accepted: 2015-11-20

Published Online: 2016-3-30

Published in Print: 2016-6-1

You are currently not able to access this content.

Articles in the same Issue

https://doi.org/10.1515/ap-2016-0030

Keywords for this article

Fasciola hepatica; immune response; DNA vaccine; phosphoglycerate kinase